Michael Barbella, Managing Editor06.15.23
George Dyer, M.D., has been elected to OrthoPediatrics Corp.'s Board of Directors at its annual stockholders meeting earlier this week.
Dyer, along with re-elected directors David R. Pelizzon, Harald Ruf, and Terry D. Schlotterback, will serve three-year terms (expiring in 2026).
“I am extremely proud to welcome George to our Board of Directors. He is a renowned orthopedic surgeon who continues to advance the field of upper extremity complex trauma reconstruction through his clinical expertise, innovation, teaching and service," OrthoPediatrics President/CEO David Bailey said. "His insights will meaningfully contribute to our product portfolio strategy and development as well as our clinical training programs. The board will benefit from George’s perspective and leadership.”
Dyer is currently an attending upper extremity surgeon on both the Hand and Upper Extremity Service and the Orthopedic Trauma Service at Mass General Brigham in Boston. He first joined the staff at Mass General Brigham in 2008. Additionally, Dyer is an associate professor of Orthopedic Surgery at Harvard Medical School, a position he has held since 2017. He graduated from Harvard Medical School, the Harvard Combined Orthopedic Residency Program, and the Hand and Upper Extremity Fellowship of the Brigham and Women’s Hospital. Dyer specializes in upper extremity adult trauma surgery, as well as complex post-traumatic reconstruction of the shoulder, elbow, wrist and hand in adults. In addition to his roles with Brigham and Women’s Hospital and Harvard Medical School, Dyer serves in the U.S. Navy, Medical Corps (reserve).
“I am thrilled to be elected to the OrthoPediatrics Board of Directors," Dyer stated. "In my career I have faced the challenge of not having implants that match a patients’ anatomy, so I understand firsthand how important the company’s 49 surgical systems are for improving clinical outcomes in pediatric orthopedics. I am eager to contribute to the company’s strategic plans to further advance pediatric orthopedics and treat the next 650,000 children.”
Founded in 2006, OrthoPediatrics is focused exclusively on advancing the field of pediatric orthopedics. As such it has developed a comprehensive product offering of 49 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and more than 70 countries outside the United States.
Dyer, along with re-elected directors David R. Pelizzon, Harald Ruf, and Terry D. Schlotterback, will serve three-year terms (expiring in 2026).
“I am extremely proud to welcome George to our Board of Directors. He is a renowned orthopedic surgeon who continues to advance the field of upper extremity complex trauma reconstruction through his clinical expertise, innovation, teaching and service," OrthoPediatrics President/CEO David Bailey said. "His insights will meaningfully contribute to our product portfolio strategy and development as well as our clinical training programs. The board will benefit from George’s perspective and leadership.”
Dyer is currently an attending upper extremity surgeon on both the Hand and Upper Extremity Service and the Orthopedic Trauma Service at Mass General Brigham in Boston. He first joined the staff at Mass General Brigham in 2008. Additionally, Dyer is an associate professor of Orthopedic Surgery at Harvard Medical School, a position he has held since 2017. He graduated from Harvard Medical School, the Harvard Combined Orthopedic Residency Program, and the Hand and Upper Extremity Fellowship of the Brigham and Women’s Hospital. Dyer specializes in upper extremity adult trauma surgery, as well as complex post-traumatic reconstruction of the shoulder, elbow, wrist and hand in adults. In addition to his roles with Brigham and Women’s Hospital and Harvard Medical School, Dyer serves in the U.S. Navy, Medical Corps (reserve).
“I am thrilled to be elected to the OrthoPediatrics Board of Directors," Dyer stated. "In my career I have faced the challenge of not having implants that match a patients’ anatomy, so I understand firsthand how important the company’s 49 surgical systems are for improving clinical outcomes in pediatric orthopedics. I am eager to contribute to the company’s strategic plans to further advance pediatric orthopedics and treat the next 650,000 children.”
Founded in 2006, OrthoPediatrics is focused exclusively on advancing the field of pediatric orthopedics. As such it has developed a comprehensive product offering of 49 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and more than 70 countries outside the United States.